INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
'Clear the Shelters' event going on today
If you're looking to add a dog or cat to your home, Saturday is the day to do it.
Four air ambulances called to Decatur Co. crash
Four air ambulances were called to the scene of a multi-car crash on State Road 3 in Decatur County Friday night.
Amid GOP endorsements, who is Eric Holcomb?
Before his sudden ascension to lieutenant governor in March, it's likely few Hoosiers outside of the political establishment had heard of…
ALERT: Weekend Heat Index 100+
Temps and humidity back off early next week!
Woman prints police-support stickers to give out
In light of recent attacks on officers, a Brownsburg woman is turning to her printers to show she cares - especially after police…